Robinson R22 Beta II — Training Manual

This document is a clinical practice guideline published by KDIGO for the evaluation and management of chronic kidney disease (CKD). It provides comprehensive recommendations based on the latest research and expert consensus to improve patient outcomes in CKD management. The guideline is intended for healthcare professionals involved in the care of patients with CKD, including nephrologists, primary care physicians, and allied health professionals. It covers various aspects of CKD, including diagnosis, risk assessment, management strategies, and recommendations for medication management. The document emphasizes a patient-centered approach and highlights the importance of shared decision-making in the management of CKD.

• CKD is defined as abnormalities of kidney structure or function present for at least 3 months.
• GFR categories are classified from G1 (≥90 ml/min/1.73 m²) to G5 (<15 ml/min/1.73 m²).
• Albuminuria categories range from A1 (normal to mildly increased) to A3 (severely increased).
• Early detection and management of CKD can significantly improve patient outcomes.
• A multidisciplinary approach is essential for effective CKD management.